Šárka Sirůčková

Šárka Sirůčková is an experienced professional in investor relations and venture capital, currently serving as an Investor Relations Partner and Venture Associate at Next Sequence® since May 2023, where responsibilities include raising a $25M fund and managing investor relations. Prior experience includes working as an HTA Consultant at Symmetron from November 2021 to June 2024, where Šárka focused on market access strategies for pharmaceuticals, as well as project management and client relations. Earlier roles include project coordination and communications at Symmetron, where significant contributions resulted in revenue growth and enhanced engagement metrics. Additional experience encompasses consulting for a stealth biotech startup, operational support at Bontia, and an internship at the Edinburgh University Sports Union, alongside comprehensive education in bioscience entrepreneurship and biotechnology from UCL and The University of Edinburgh.